Abstract

The development of craniofacial skeletal structures is fascinatingly complex and elucidation of the underlying mechanisms will not only provide novel scientific insights, but also help develop more effective clinical approaches to the treatment and/or prevention of the numerous congenital craniofacial malformations. To this end, we performed a genome-wide analysis of RNA transcription from non-coding regulatory elements by CAGE-sequencing of the facial mesenchyme of human embryos and cross-checked the active enhancers thus identified against genes, identified by GWAS for the normal range human facial appearance. Among the identified active cis-enhancers, several belonged to the components of the PI3/AKT/mTORC1/autophagy pathway. To assess the functional role of this pathway, we manipulated it both genetically and pharmacologically in mice and zebrafish. These experiments revealed that mTORC1 signaling modulates craniofacial shaping at the stage of skeletal mesenchymal condensations, with subsequent fine-tuning during clonal intercalation. This ability of mTORC1 pathway to modulate facial shaping, along with its evolutionary conservation and ability to sense external stimuli, in particular dietary amino acids, indicate that the mTORC1 pathway may play a role in facial phenotypic plasticity. Indeed, the level of protein in the diet of pregnant female mice influenced the activity of mTORC1 in fetal craniofacial structures and altered the size of skeletogenic clones, thus exerting an impact on the local geometry and craniofacial shaping. Overall, our findings indicate that the mTORC1 signaling pathway is involved in the effect of environmental conditions on the shaping of craniofacial structures.

Children’s faces resemble their parents to various degrees. Here they show that the maternal diet affects the facial appearances of newborns and that inherited and adaptive mechanisms sculpturing facial bones are linked via dietary protein levels and the mTOR signaling pathway.

Details

Title
The level of protein in the maternal murine diet modulates the facial appearance of the offspring via mTORC1 signaling
Author
Xie, Meng 1   VIAFID ORCID Logo  ; Kaiser, Markéta 2   VIAFID ORCID Logo  ; Gershtein, Yaakov 3 ; Schnyder, Daniela 4   VIAFID ORCID Logo  ; Deviatiiarov, Ruslan 5   VIAFID ORCID Logo  ; Gazizova, Guzel 6 ; Shagimardanova, Elena 7 ; Zikmund, Tomáš 2   VIAFID ORCID Logo  ; Kerckhofs, Greet 8 ; Ivashkin, Evgeny 9 ; Batkovskyte, Dominyka 10   VIAFID ORCID Logo  ; Newton, Phillip T. 11   VIAFID ORCID Logo  ; Andersson, Olov 12   VIAFID ORCID Logo  ; Fried, Kaj 13   VIAFID ORCID Logo  ; Gusev, Oleg 5 ; Zeberg, Hugo 10   VIAFID ORCID Logo  ; Kaiser, Jozef 2   VIAFID ORCID Logo  ; Adameyko, Igor 14   VIAFID ORCID Logo  ; Chagin, Andrei S. 4 

 Karolinska Institutet, Department of Physiology and Pharmacology, Stockholm, Sweden (GRID:grid.4714.6) (ISNI:0000 0004 1937 0626); Karolinska Institute, Department of Biosciences and Nutrition, Flemingsberg, Sweden (GRID:grid.4714.6) (ISNI:0000 0004 1937 0626); Peking University, School of Psychological and Cognitive Sciences, PKU-IDG/McGovern Institute for Brain Research, Beijing, China (GRID:grid.11135.37) (ISNI:0000 0001 2256 9319) 
 Brno University of Technology, Central European Institute of Technology, Brno, Czech Republic (GRID:grid.4994.0) (ISNI:0000 0001 0118 0988) 
 Medical University of Vienna, Department of Neuroimmunology, Center for Brain Research, Vienna, Austria (GRID:grid.22937.3d) (ISNI:0000 0000 9259 8492) 
 Karolinska Institutet, Department of Physiology and Pharmacology, Stockholm, Sweden (GRID:grid.4714.6) (ISNI:0000 0004 1937 0626); Sahlgrenska Academy at University of Gothenburg, Centre for Bone and Arthritis Research, Institute of Medicine, Gothenburg, Sweden (GRID:grid.8761.8) (ISNI:0000 0000 9919 9582) 
 Kazan Federal University, Regulatory Genomics Research Center, Kazan, Russia (GRID:grid.77268.3c) (ISNI:0000 0004 0543 9688); Endocrinology Research Center, Moscow, Russia (GRID:grid.465364.6) (ISNI:0000 0004 0619 9372); Life Improvement by Future Technologies (LIFT) Center, Moscow, Russia (GRID:grid.465364.6); Juntendo University, Intractable Disease Research Center, Tokyo, Japan (GRID:grid.258269.2) (ISNI:0000 0004 1762 2738) 
 Kazan Federal University, Regulatory Genomics Research Center, Kazan, Russia (GRID:grid.77268.3c) (ISNI:0000 0004 0543 9688) 
 Kazan Federal University, Regulatory Genomics Research Center, Kazan, Russia (GRID:grid.77268.3c) (ISNI:0000 0004 0543 9688); Life Improvement by Future Technologies (LIFT) Center, Moscow, Russia (GRID:grid.77268.3c) 
 Biomechanics Lab, Institute of Mechanics, Materials, and Civil Engineering (iMMC), UCLouvain, Louvain-la-Neuve, Belgium (GRID:grid.7942.8) (ISNI:0000 0001 2294 713X); Pole of Morphology, Institute of Experimental and Clinical Research (IREC), UCLouvain, Woluwe, Belgium (GRID:grid.7942.8) (ISNI:0000 0001 2294 713X); KU Leuven, Department of Materials Engineering, Leuven, Belgium (GRID:grid.5596.f) (ISNI:0000 0001 0668 7884); Prometheus, Division for Skeletal Tissue Engineering, KU Leuven, Leuven, Belgium (GRID:grid.5596.f) (ISNI:0000 0001 0668 7884) 
 A.N. Severtsov Institute of Ecology and Evolution, Russian Academy of Sciences, Moscow, Russia (GRID:grid.437665.5) (ISNI:0000 0001 1088 7934); Russian Academy of Sciences, Department of Developmental and Comparative Physiology, N.K. Koltsov Institute of Developmental Biology, Moscow, Russia (GRID:grid.4886.2) (ISNI:0000 0001 2192 9124) 
10  Karolinska Institutet, Department of Physiology and Pharmacology, Stockholm, Sweden (GRID:grid.4714.6) (ISNI:0000 0004 1937 0626) 
11  Karolinska Institutet, Department of Physiology and Pharmacology, Stockholm, Sweden (GRID:grid.4714.6) (ISNI:0000 0004 1937 0626); Karolinska Institutet, Department of Women’s and Children’s Health, Stockholm, Sweden (GRID:grid.4714.6) (ISNI:0000 0004 1937 0626); Astrid Lindgren Children’s hospital, Stockholm, Sweden (GRID:grid.24381.3c) (ISNI:0000 0000 9241 5705) 
12  Karolinska Institutet, Department of Cell and Molecular Biology, Stockholm, Sweden (GRID:grid.4714.6) (ISNI:0000 0004 1937 0626) 
13  Karolinska Institutet, Department of Neuroscience, Stockholm, Sweden (GRID:grid.4714.6) (ISNI:0000 0004 1937 0626) 
14  Karolinska Institutet, Department of Physiology and Pharmacology, Stockholm, Sweden (GRID:grid.4714.6) (ISNI:0000 0004 1937 0626); Medical University of Vienna, Department of Neuroimmunology, Center for Brain Research, Vienna, Austria (GRID:grid.22937.3d) (ISNI:0000 0000 9259 8492) 
Pages
2367
Publication year
2024
Publication date
2024
Publisher
Nature Publishing Group
e-ISSN
20411723
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2986722990
Copyright
© The Author(s) 2024. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.